Measuring heart rate variability with wavelet thresholds and energy components in healthy subjects and patients with congestive heart failure

Jou Wei Lin, Juey Jen Hwang, Liang Yu Lin, Jiunn Lee Lin

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Analysis of wavelet thresholds and energy components can be used to differentiate patients with congestive heart failure (CHF) from healthy subjects and to demonstrate the improvement of heart rate variability after treatment with beta-blockers in the patient group. Methods: Nine patients with CHF without concurrent beta-blocker therapy and 15 healthy volunteers were recruited and received 24-hour Holter recording. Wavelet thresholds and energy components were calculated. The patients with CHF were then treated with atenolol for 3 months. Another Holter recording was repeated and associated wavelet parameters were estimated. Results: Wavelet thresholds were statistically higher in normal subjects than those derived from patients with CHF (62.40 ± 20.65 vs. 16.90 ± 9.72, p < 0.001). The difference was still significant after control of heart rate and the total number of heart beats (74.85 ± 22.68 vs. 32.51 ± 18.73, p < 0.001). The energy component of HRV in the finest wavelet domain was also significantly higher in the normal subjects (243.01 ± 237.69 × 10-6 vs. 40.65 ± 39.65 × 10-6, p = 0.001). These two measures increased after treatment with beta-blockers in the patients with CHF, but not to the extent of those of normal subjects. Conclusion: Analysis of wavelet thresholds and energy components has provided robust and accurate measurements for background HRV.

Original languageEnglish
Pages (from-to)207-214
Number of pages8
JournalCardiology
Volume106
Issue number4
DOIs
Publication statusPublished - Nov 22 2006
Externally publishedYes

Fingerprint

Healthy Volunteers
Heart Failure
Heart Rate
Wavelet Analysis
Atenolol
Therapeutics

Keywords

  • Congestive heart failure
  • Heart rate variability
  • Wavelet thresholds

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)

Cite this

Measuring heart rate variability with wavelet thresholds and energy components in healthy subjects and patients with congestive heart failure. / Lin, Jou Wei; Hwang, Juey Jen; Lin, Liang Yu; Lin, Jiunn Lee.

In: Cardiology, Vol. 106, No. 4, 22.11.2006, p. 207-214.

Research output: Contribution to journalArticle

@article{637685f062c34852a2a3a523304ff17d,
title = "Measuring heart rate variability with wavelet thresholds and energy components in healthy subjects and patients with congestive heart failure",
abstract = "Background: Analysis of wavelet thresholds and energy components can be used to differentiate patients with congestive heart failure (CHF) from healthy subjects and to demonstrate the improvement of heart rate variability after treatment with beta-blockers in the patient group. Methods: Nine patients with CHF without concurrent beta-blocker therapy and 15 healthy volunteers were recruited and received 24-hour Holter recording. Wavelet thresholds and energy components were calculated. The patients with CHF were then treated with atenolol for 3 months. Another Holter recording was repeated and associated wavelet parameters were estimated. Results: Wavelet thresholds were statistically higher in normal subjects than those derived from patients with CHF (62.40 ± 20.65 vs. 16.90 ± 9.72, p < 0.001). The difference was still significant after control of heart rate and the total number of heart beats (74.85 ± 22.68 vs. 32.51 ± 18.73, p < 0.001). The energy component of HRV in the finest wavelet domain was also significantly higher in the normal subjects (243.01 ± 237.69 × 10-6 vs. 40.65 ± 39.65 × 10-6, p = 0.001). These two measures increased after treatment with beta-blockers in the patients with CHF, but not to the extent of those of normal subjects. Conclusion: Analysis of wavelet thresholds and energy components has provided robust and accurate measurements for background HRV.",
keywords = "Congestive heart failure, Heart rate variability, Wavelet thresholds",
author = "Lin, {Jou Wei} and Hwang, {Juey Jen} and Lin, {Liang Yu} and Lin, {Jiunn Lee}",
year = "2006",
month = "11",
day = "22",
doi = "10.1159/000093124",
language = "English",
volume = "106",
pages = "207--214",
journal = "Cardiology",
issn = "0008-6312",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Measuring heart rate variability with wavelet thresholds and energy components in healthy subjects and patients with congestive heart failure

AU - Lin, Jou Wei

AU - Hwang, Juey Jen

AU - Lin, Liang Yu

AU - Lin, Jiunn Lee

PY - 2006/11/22

Y1 - 2006/11/22

N2 - Background: Analysis of wavelet thresholds and energy components can be used to differentiate patients with congestive heart failure (CHF) from healthy subjects and to demonstrate the improvement of heart rate variability after treatment with beta-blockers in the patient group. Methods: Nine patients with CHF without concurrent beta-blocker therapy and 15 healthy volunteers were recruited and received 24-hour Holter recording. Wavelet thresholds and energy components were calculated. The patients with CHF were then treated with atenolol for 3 months. Another Holter recording was repeated and associated wavelet parameters were estimated. Results: Wavelet thresholds were statistically higher in normal subjects than those derived from patients with CHF (62.40 ± 20.65 vs. 16.90 ± 9.72, p < 0.001). The difference was still significant after control of heart rate and the total number of heart beats (74.85 ± 22.68 vs. 32.51 ± 18.73, p < 0.001). The energy component of HRV in the finest wavelet domain was also significantly higher in the normal subjects (243.01 ± 237.69 × 10-6 vs. 40.65 ± 39.65 × 10-6, p = 0.001). These two measures increased after treatment with beta-blockers in the patients with CHF, but not to the extent of those of normal subjects. Conclusion: Analysis of wavelet thresholds and energy components has provided robust and accurate measurements for background HRV.

AB - Background: Analysis of wavelet thresholds and energy components can be used to differentiate patients with congestive heart failure (CHF) from healthy subjects and to demonstrate the improvement of heart rate variability after treatment with beta-blockers in the patient group. Methods: Nine patients with CHF without concurrent beta-blocker therapy and 15 healthy volunteers were recruited and received 24-hour Holter recording. Wavelet thresholds and energy components were calculated. The patients with CHF were then treated with atenolol for 3 months. Another Holter recording was repeated and associated wavelet parameters were estimated. Results: Wavelet thresholds were statistically higher in normal subjects than those derived from patients with CHF (62.40 ± 20.65 vs. 16.90 ± 9.72, p < 0.001). The difference was still significant after control of heart rate and the total number of heart beats (74.85 ± 22.68 vs. 32.51 ± 18.73, p < 0.001). The energy component of HRV in the finest wavelet domain was also significantly higher in the normal subjects (243.01 ± 237.69 × 10-6 vs. 40.65 ± 39.65 × 10-6, p = 0.001). These two measures increased after treatment with beta-blockers in the patients with CHF, but not to the extent of those of normal subjects. Conclusion: Analysis of wavelet thresholds and energy components has provided robust and accurate measurements for background HRV.

KW - Congestive heart failure

KW - Heart rate variability

KW - Wavelet thresholds

UR - http://www.scopus.com/inward/record.url?scp=33751076308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751076308&partnerID=8YFLogxK

U2 - 10.1159/000093124

DO - 10.1159/000093124

M3 - Article

VL - 106

SP - 207

EP - 214

JO - Cardiology

JF - Cardiology

SN - 0008-6312

IS - 4

ER -